In this podcast, Finnegan attorneys Mark Feldstein, Cora Holt, and Tom Irving discuss the impacts of the recent Federal Circuit cases GSK v. Teva and Amarin v. Hikma.
A closed captioning version is available here.
Audio Only:
Tags
United States Court of Appeals for the Federal Circuit (CAFC), drugs, Food and Drug Administration (FDA)
